Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001919246-26-000047
Filing Date
2026-04-01
Accepted
2026-04-01 17:45:39
Documents
2
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wk-form4a_1775079936.html 4/A  
1 FORM 4/A wk-form4a_1775079936.xml 4/A 10033
2 EX-24 pths-section16_poaxv5xfrie.htm EX-24 6909
  Complete submission text file 0001919246-26-000047.txt   18636
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005
Business Address
Friedberg Ezra M (Reporting) CIK: 0001679440 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41964 | Film No.: 26829696

Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Issuer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)